Table 1

Demographics, reattendance rates and STI rates at reattendance

Demographics of all patientsControl group (N=266)Text group (N=273)p Value
Gender, n (%)118 (45%) male125 (46%) male0.80
148 (55%) female148 (54%) female
Median age (range)24 (15–65)23 (15–61)1.00
Ethnicity, n (%)
 Black137 (51%)153 (56%)0.30
 White82 (31%)77 (28%)0.51
 Other47 (18%)43 (16%)1.00
Reattendance rates by initial risk category (%, 95% CI)
 Chlamydia41/123 (33%, 26 to 42)43/121 (36%, 28 to 44)0.79
 Gonorrhoea7/21 (33%, 17 to 55)4/21 (19%, 7 to 41)0.48
 Window period10/39 (26%, 14 to 41)5/36 (14%, 6 to 29)0.25
 Women receiving emergency contraception25/56 (45%, 31 to 56)27/60 (45%, 33 to 58)1.00
 Other risks*9/27 (35%, 19 to 52)11/35 (31%, 18 to 48)1.00
 Total reattendance92/266 (35%, 29 to 40)90/273 (33%, 28 to 39)0.78
Reattendance rates by ethnicity, age and gender (%, 95% CI)
 Reattendance rate white31/82 (38%, 28 to 49)21/77 (27%, 19 to 38)0.18
 Reattendance rate black†46/137 (34%, 26 to 41)56/153 (37%, 29 to 44)0.54
 Reattendance rate other15/47 (32%, 20 to 46)12/43 (28%, 16 to 43)0.82
 Reattendance rate 15–25-years-old58/150 (39%, 31 to 47)68/179 (38%, 31 to 45)0.91
 Reattendance rate >25-years-old34/116 (29%, 21 to 38)21/94 (22%, 15 to 32)0.34
 Reattendance rate males37/118 (31%, 24 to 40)26/125 (21%, 15 to 29)0.19
 Reattendance rate females55/148 (37%, 29 to 45)63/148 (43%, 35 to 51)0.34
STI rates (%, 95% CI)
 STI diagnosed in reattending patients15/91 (17%, 10 to 26)‡13/90 (14%, 9 to 23)§0.84
  • *Patients with hepatitis or syphilis, sex workers and MSM.

  • †Black British, African or Caribbean.

  • ‡Five Non-gonococcal urethritis, two chlamydia, two gonorrhoea, two pelvic inflammatory disease, two genital warts, one chlamydia with herpes, one trichomonas vaginalis.

  • §Five chlamydia, two gonorrhoea, two chlamydia with gonorrhoea or herpes, one trichomonas vaginalis, one pelvic inflammatory disease, one genital herpes, one genital warts.

  • MSM, men who have sex with men; STI, sexually transmitted infection.